# A Single and Multiple Ascending Dose Study of BMS-986318 in Healthy Participants

> **NCT04082741** · PHASE1 · WITHDRAWN · sponsor: **Bristol-Myers Squibb**

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** BMS-986318
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04082741
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-07-18
- **Primary completion:** 2019-09-12
- **Final completion:** 2019-09-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study is no longer required based on nonclinical drug data
- **Last updated:** 2020-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04082741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04082741, "A Single and Multiple Ascending Dose Study of BMS-986318 in Healthy Participants". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04082741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*